National Health (Weighted average disclosed price – first transitional disclosure cycle) Determination 2011

Instrument number PB 81 of 2011

National Health Act 1953

I, FELICITY McNEILL, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this determination under subsection 99ADB(4) and paragraph 99ADH(1)(aa) of the National Health Act 1953.

Dated 13 December 2011

 

 

 

 

 

 

 

 

 

FELICITY McNEILL

 

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health and Ageing

 

 

Part 1   Preliminary

1 Name of Determination

 (1) This Determination is the National Health (Weighted average disclosed price – first transitional disclosure cycle) Determination 2011.

 (2) This Determination may also be cited as PB 81 of 2011.

2 Commencement

  This Determination commences on the day after it is registered.

3                             Revocation

 

The Determination titled ‘Determination made pursuant to subsections 99ADB(4) and 99ADB(5) of the National Health Act 1953’ made on 22 September 2010 and also cited as PB 43 of 2010 is revoked.

4                             Definitions

 

In this Determination:

 

Act means the National Health Act 1953.

 

adjusted approved ex-manufacturer price has the same meaning as in subsection 99ADB(1) of the Act.

 

adjusted approved price to pharmacists has the same meaning as in subsection 99ADB(1) of the Act.

 

first transitional disclosure cycle has the same meaning as in Part 2 Transitional, regulation 4, of the National Health (Pharmaceutical Benefits) Amendment Regulations 2010 (No.5) (296/2010).

 

unadjusted price reduction has the same meaning as in subsection 99ADB(1) of the Act.

 

weighted average disclosed price has the same meaning as in subsection 99ADB(1) of the Act.

 

 

 

 

 

 

 

5                             Weighted average disclosed price for brands of pharmaceutical items – unadjusted price reduction is at least 10%

 

For subsection 99ADB(4) of the Act, the weighted average disclosed price specified in column 3 of an item in Schedule 1 is the weighted average disclosed price for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 1.

 

 

6                             Weighted average disclosed price for brands of pharmaceutical items – unadjusted price reduction is less than 10%

 

For subsection 99ADB(4) of the Act, the weighted average disclosed price specified in column 3 of an item in Schedule 2 is the weighted average disclosed price for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 2.

 

 

7                             Adjusted approved ex-manufacturer price for brands of pharmaceutical items – unadjusted price reduction is at least 10%

 

For paragraph 99ADB(4) of the Act, the adjusted approved ex-manufacturer price for a brand of pharmaceutical item specified in column 2 of Schedule 1 is an amount equal to the amount of the weighted average disclosed price of that brand of pharmaceutical item determined under section 5 of this instrument.

 

 

8                             Adjusted approved price to pharmacists for brands of pharmaceutical items – unadjusted price reduction is at least 10%

 

For paragraph 99ADB(4) of the Act, the adjusted approved price to pharmacists specified in column 4 of an item in Schedule 1 is the adjusted approved price to pharmacists for the brand of pharmaceutical item specified in column 2 of the same item in Schedule 1.

 

 

9                             Reduction Day

 

For paragraph 99ADH(1)(aa) of the Act, a brand of pharmaceutical item in the first transitional disclosure cycle with a data collection period ending at the end of
30 September 2011 has a reduction day of 1 April 2012.

Schedule 1    

 

Brands of pharmaceutical items – unadjusted price reduction is at least 10%

 

 

 

Column 1

Column 2

Column 3

Column 4

Item

Brand of Pharmaceutical Item

Weighted average disclosed price

Adjusted approved price to pharmacists

 

Listed Drug

Form

Manner of administration

Brand

 

 

1

Alendronic Acid

Tablet 40 mg (as alendronate sodium)

Oral

Fosamax 40 mg

56.35

60.59

2

Alendronic Acid

Tablet 70 mg (as alendronate sodium)

Oral

Adronat

17.07

18.35

3

Alendronic Acid

Tablet 70 mg (as alendronate sodium)

Oral

Alendro Once Weekly

17.07

18.35

4

Alendronic Acid

Tablet 70 mg (as alendronate sodium)

Oral

Alendrobell 70mg

17.07

18.35

5

Alendronic Acid

Tablet 70 mg (as alendronate sodium)

Oral

Alendronate Sandoz

17.07

18.35

6

Alendronic Acid

Tablet 70 mg (as alendronate sodium)

Oral

Alendronate-GA

17.07

18.35

7

Alendronic Acid

Tablet 70 mg (as alendronate sodium)

Oral

APO-Alendronate

17.07

18.35

8

Alendronic Acid

Tablet 70 mg (as alendronate sodium)

Oral

Chem mart Alendronate 70mg

17.07

18.35

9

Alendronic Acid

Tablet 70 mg (as alendronate sodium)

Oral

Fosamax Once Weekly

17.07

18.35

10

Alendronic Acid

Tablet 70 mg (as alendronate sodium)

Oral

Ossmax 70mg

17.07

18.35

11

Alendronic Acid

Tablet 70 mg (as alendronate sodium)

Oral

Terry White Chemists Alendronate 70mg

17.07

18.35

12

Cisplatin

I.V. injection 10 mg in 10 mL

Injection

Pfizer Australia Pty Ltd

2.78

2.99

13

Cisplatin

I.V. injection 100 mg in 100 mL

Injection

Cisplatin Ebewe

18.79

20.20

14

Cisplatin

I.V. injection 100 mg in 100 mL

Injection

Hospira Pty Limited

18.79

20.20

15

Cisplatin

I.V. injection 100 mg in 100 mL

Injection

Pfizer Australia Pty Ltd

18.79

20.20

16

Cisplatin

I.V. injection 50 mg in 50 mL

Injection

Hospira Pty Limited

7.46

8.02

17

Cisplatin

I.V. injection 50 mg in 50 mL

Injection

Pfizer Australia Pty Ltd

7.46

8.02

18

Fluconazole

Capsule 100 mg

Oral

DBL Fluconazole

55.24

59.39

19

Fluconazole

Capsule 100 mg

Oral

Diflucan

55.24

59.39

20

Fluconazole

Capsule 100 mg

Oral

Dizole 100

55.24

59.39

21

Fluconazole

Capsule 100 mg

Oral

Fluconazole Sandoz

55.24

59.39

22

Fluconazole

Capsule 100 mg

Oral

Ozole

55.24

59.39

23

Fluconazole

Capsule 200 mg

Oral

APO-Fluconazole

107.61

115.70

24

Fluconazole

Capsule 200 mg

Oral

DBL Fluconazole

107.61

115.70

25

Fluconazole

Capsule 200 mg

Oral

Diflucan

107.61

115.70

26

Fluconazole

Capsule 200 mg

Oral

Dizole 200

107.61

115.70

27

Fluconazole

Capsule 200 mg

Oral

Fluconazole Sandoz

107.61

115.70

28

Fluconazole

Capsule 200 mg

Oral

Fluzole 200

107.61

115.70

29

Fluconazole

Capsule 200 mg

Oral

Ozole

107.61

115.70

30

Fluconazole

Capsule 50 mg

Oral

DBL Fluconazole

28.36

30.49

31

Fluconazole

Capsule 50 mg

Oral

Diflucan

28.36

30.49

32

Fluconazole

Capsule 50 mg

Oral

Dizole 50

28.36

30.49

33

Fluconazole

Capsule 50 mg

Oral

Fluconazole Sandoz

28.36

30.49

34

Fluconazole

Capsule 50 mg

Oral

Fluzole 50

28.36

30.49

35

Fluconazole

Capsule 50 mg

Oral

Ozole

28.36

30.49

36

Topiramate

Capsule 15 mg

Oral

Topamax Sprinkle

17.68

19.01

37

Topiramate

Capsule 25 mg

Oral

Topamax Sprinkle

23.90

25.70

38

Topiramate

Capsule 50 mg

Oral

Topamax Sprinkle

39.84

42.84

39

Topiramate

Tablet 100 mg

Oral

APO-Topiramate

62.75

67.47

40

Topiramate

Tablet 100 mg

Oral

Epiramax 100

62.75

67.47

41

Topiramate

Tablet 100 mg

Oral

RBX Topiramate

62.75

67.47

42

Topiramate

Tablet 100 mg

Oral

Tamate

62.75

67.47

43

Topiramate

Tablet 100 mg

Oral

Topamax

62.75

67.47

44

Topiramate

Tablet 100 mg

Oral

Topiramate generichealth

62.75

67.47

45

Topiramate

Tablet 100 mg

Oral

Topiramate Sandoz

62.75

67.47

46

Topiramate

Tablet 100 mg

Oral

Topiramate-GA

62.75

67.47

47

Topiramate

Tablet 200 mg

Oral

APO-Topiramate

105.41

113.34

48

Topiramate

Tablet 200 mg

Oral

Epiramax 200

105.41

113.34

49

Topiramate

Tablet 200 mg

Oral

RBX Topiramate

105.41

113.34

50

Topiramate

Tablet 200 mg

Oral

Tamate

105.41

113.34

51

Topiramate

Tablet 200 mg

Oral

Topamax

105.41

113.34

52

Topiramate

Tablet 200 mg

Oral

Topiramate generichealth

105.41

113.34

53

Topiramate

Tablet 200 mg

Oral

Topiramate Sandoz

105.41

113.34

54

Topiramate

Tablet 200 mg

Oral

Topiramate-GA

105.41

113.34

55

Topiramate

Tablet 25 mg

Oral

APO-Topiramate

24.30

26.13

56

Topiramate

Tablet 25 mg

Oral

Epiramax 25

24.30

26.13

57

Topiramate

Tablet 25 mg

Oral

RBX Topiramate

24.30

26.13

58

Topiramate

Tablet 25 mg

Oral

Tamate

24.30

26.13

59

Topiramate

Tablet 25 mg

Oral

Topamax

24.30

26.13

60

Topiramate

Tablet 25 mg

Oral

Topiramate generichealth

24.30

26.13

61

Topiramate

Tablet 25 mg

Oral

Topiramate Sandoz

24.30

26.13

62

Topiramate

Tablet 25 mg

Oral

Topiramate-GA

24.30

26.13

63

Topiramate

Tablet 50 mg

Oral

APO-Topiramate

39.89

42.89

64

Topiramate

Tablet 50 mg

Oral

Epiramax 50

39.89

42.89

65

Topiramate

Tablet 50 mg

Oral

RBX Topiramate

39.89

42.89

66

Topiramate

Tablet 50 mg

Oral

Tamate

39.89

42.89

67

Topiramate

Tablet 50 mg

Oral

Topamax

39.89

42.89

68

Topiramate

Tablet 50 mg

Oral

Topiramate generichealth

39.89

42.89

69

Topiramate

Tablet 50 mg

Oral

Topiramate Sandoz

39.89

42.89

70

Topiramate

Tablet 50 mg

Oral

Topiramate-GA

39.89

42.89

 

 

 

 

 

 

 

Schedule 2    

 

Brands of pharmaceutical items – unadjusted price reduction is less than 10%

 

 

 

Column 1

Column 2

Column 3

Item

Brand of Pharmaceutical Item

Weighted average disclosed price

 

Listed Drug

Form

Manner of administration

Brand

 

1

Levodopa with Carbidopa

Tablet 100 mg-25 mg (anhydrous)

Oral

Kinson

25.47

2

Levodopa with Carbidopa

Tablet 100 mg-25 mg (anhydrous)

Oral

Sinemet 100/25

25.47

3

Levodopa with Carbidopa

Tablet 250 mg-25 mg (anhydrous)

Oral

Levo/Carbidopa Sandoz

31.41

4

Levodopa with Carbidopa

Tablet 250 mg-25 mg (anhydrous)

Oral

Sinemet

31.41

5

Naltrexone

Tablet containing naltrexone hydrochloride 50 mg

Oral

Naltrexone generichealth

108.89

6

Naltrexone

Tablet containing naltrexone hydrochloride 50 mg

Oral

ReVia

108.89

 

 

 

Note

1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.